Serologicals Acquires Upstate and Will Issue Shares to Molecular Devices

Serologicals will acquire Upstate Group for $205 million in stock and cash, according to SEC documents filed this week.

As part of the acquisition, Serologicals will issue shares to Molecular Devices and other Upstate shareholders, the company said in its 8-K filing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.